Skip to main content
In stock|Targeted Therapy (Investigational)

Alisertib

Oncology TypeBoth (Solid & Hematologic)
Drug Class / MechanismPolo-Like / Aurora Kinase Inhibitor
No Image
Description

Alisertib is classified as a Polo-Like / Aurora Kinase Inhibitor, sourced for use within our Targeted Therapy (Investigational) portfolio. Reach out to our team for full regulatory documentation, pricing, and current availability.

Therapeutic CategoryTargeted Therapy (Investigational)
Oncology TypeBoth (Solid & Hematologic)

Send Inquiry

Submit your details to get a formal quote for this product.

Step 1 of 3